Autophagy induction contributes to GDC-0349 resistance in head and neck squamous cell carcinoma (HNSCC) cells
- 1 August 2016
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 477 (2) , 174-180
Abstract
No abstract availableKeywords
Funding Information
- NSFC
This publication has 36 references indexed in Scilit:
- The anti-esophageal cancer cell activity by a novel tyrosine/phosphoinositide kinase inhibitor PP121Biochemical and Biophysical Research Communications, 2015
- mTOR inhibitors in cancer therapyCancer Letters, 2012
- mTOR as a Molecular Target in HPV-Associated Oral and Cervical Squamous CarcinomasClinical Cancer Research, 2012
- mTOR Signaling in Growth Control and DiseaseCell, 2012
- Pushing the Envelope in the mTOR Pathway: The Second Generation of InhibitorsMolecular Cancer Therapeutics, 2011
- EGFR–PI3K–AKT–mTOR signaling in head and neck squamous cell carcinomas: attractive targets for molecular-oriented therapyExpert Opinion on Therapeutic Targets, 2010
- Molecular targeted therapies in head and neck cancer - An update of recent developements -Head & Neck Oncology, 2010
- Emerging molecular targeted therapies in the treatment of head and neck cancerExpert Opinion on Emerging Drugs, 2009
- Molecular targeted therapy of head and neck cancer: Review and clinical development challengesEuropean Journal of Cancer, 2007
- Mammalian Target of Rapamycin, a Molecular Target in Squamous Cell Carcinomas of the Head and NeckCancer Research, 2005